BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28088990)

  • 1. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Feb; 76(2):191-198. PubMed ID: 28088990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of infections in immune deficiency].
    Lange B; Neumann S; Hirsch HH; Kern WV
    Dtsch Med Wochenschr; 2014 Oct; 139(40):1999-2002. PubMed ID: 25254394
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination of children and adults with autoimmune diseases].
    Zink A
    Z Rheumatol; 2007 Mar; 66(2):101. PubMed ID: 17294059
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections.
    Singer NG; McCune WJ
    Curr Opin Rheumatol; 1999 May; 11(3):173-8. PubMed ID: 10328575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection Risk and Safety of Corticosteroid Use.
    Youssef J; Novosad SA; Winthrop KL
    Rheum Dis Clin North Am; 2016 Feb; 42(1):157-76, ix-x. PubMed ID: 26611557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders.
    Lehman JS; Murrell DF; Camilleri MJ; Kalaaji AN
    Dermatol Clin; 2011 Oct; 29(4):591-8. PubMed ID: 21925003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
    Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bacterial pneumonitis on development of pneumocystosis in rats.
    Pesanti EL
    Am Rev Respir Dis; 1982 Jun; 125(6):723-6. PubMed ID: 6979959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization in children and adolescents with rheumatic diseases].
    Minden K; Niewerth M; Borte M; Singendonk W; Haas JP
    Z Rheumatol; 2007 Mar; 66(2):111-2, 114-8, 120. PubMed ID: 17364157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucocorticoids and infection].
    Frey FJ; Speck RF
    Schweiz Med Wochenschr; 1992 Feb; 122(5):137-46. PubMed ID: 1738819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and vaccination.
    Ada G
    N Engl J Med; 2001 Oct; 345(14):1042-53. PubMed ID: 11586958
    [No Abstract]   [Full Text] [Related]  

  • 12. Invasive diseases: new vaccines and vaccination strategies.
    Crovari P
    J Prev Med Hyg; 2012 Jun; 53(2):49. PubMed ID: 23240159
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET).
    Martire B; Azzari C; Badolato R; Canessa C; Cirillo E; Gallo V; Graziani S; Lorenzini T; Milito C; Panza R; Moschese V;
    Vaccine; 2018 Jun; 36(24):3541-3554. PubMed ID: 29426658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic vaccines].
    Logunov DIu; Naroditskiĭ BS; Gintsburg AL; Vorob'ev AA
    Vestn Ross Akad Med Nauk; 2005; (1):14-9. PubMed ID: 15715149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinating the inflammatory bowel disease patient.
    Desalermos AP; Farraye FA; Wasan SK
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):91-102. PubMed ID: 25160668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S29-65. PubMed ID: 10770913
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunistic infections in patients with idiopathic inflammatory myopathies.
    Redondo-Benito A; Curran A; Villar-Gomez A; Trallero-Araguas E; Fernández-Codina A; Pinal-Fernandez I; Rodrigo-Pendás JÁ; Selva-O'Callaghan A
    Int J Rheum Dis; 2018 Feb; 21(2):487-496. PubMed ID: 29314762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infections during glucocorticoid use].
    Minderhoud TC; van Meer MPA; van Thiel RJ; den Hoed CM; van Daele PLA; Schurink CAM
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30212002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Jan; 76(1):1-9. PubMed ID: 27986132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination programs in Poland].
    Gładysz A; Rymer W; Inglot M; Rotter K; Knysz B
    Przegl Epidemiol; 2004; 58 Suppl 1():80-9. PubMed ID: 15807163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.